Literature research is an ongoing, iterative process for all scientists. A literature review is a large task that can require 60–80 hours of focused effort for regulatory professionals (1). This includes scanning the medical literature to collect adverse events and analyzing the results.

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that currently produces dementia in 5.8 million U.S citizens. This number is projected to reach 13.5 million by 2050 highlighting the urgent need for means to prevent, delay the onset, slow the progression and improve the symptoms of AD (1).

Chronic Obstructive Pulmonary Disease (COPD) describes a group of conditions which cause breathing difficulties, and includes chronic bronchitis and emphysema. The condition mainly affects older people who smoke and is typically managed by clinicians and other health professionals in a primary care setting.